SCHEMBL890889

SCHEMBL890889

[CH2]C(NCCN)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.45
MTOR P42345 1/20 0.45
RAB9A P51151 1/20 0.45
GRM7 Q14831 1/20 0.45
CYP3A4 P08684 4/20 0.43
TSHR P16473 2/20 0.43
ALOX15 P16050 2/20 0.43
TAAR1 Q96RJ0 4/20 0.43
HTR2A P28223 3/20 0.43
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
SLC6A4 P31645 2/20 0.39
CYP2C19 P33261 2/20 0.39
SLC6A3 Q01959 2/20 0.39
CYP2C9 P11712 1/20 0.39
KIF11 P52732 1/20 0.39
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
ADORA3 P0DMS8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21379853 0.79 MTOR (0.45) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL8352681 0.78 MTOR (0.74) HRH1MTORRAB9AGRM7CYP3A4
Hydrochloric Acid SCHEMBL28410803 0.77 CYP3A4 (0.75) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL8570275 0.75 HRH1 (0.45) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL4706959 0.75 CYP3A4 (0.66) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL1132349 0.75 CYP3A4 (0.66) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL3927833 0.75 CYP3A4 (0.66) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL28174803 0.75 HRH1 (0.41) HRH1MTORRAB9AGRM7CYP3A4
SCHEMBL11623788 0.75 ALDH1A1 (0.50) MTORRAB9AGRM7CYP3A4TSHR
SCHEMBL27850764 0.74 SIGMAR1 (0.45) HRH1MTORRAB9AGRM7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2510925-B1 Small-Molecule modulators of TRP-P8 activity DENDREON CORP (US) 2016-07-20 EP claimed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP claimed
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-04-05 US claimed
EP-2268273-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2011-01-05 EP claimed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO claimed
CN-101420942-A Small-molecule modulators of TRP-P8 activity DENDREON CORP (US) 2009-04-29 CN claimed
EP-1986622-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-11-05 EP claimed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US claimed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US claimed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO claimed
EP-2510925-B1 Small-Molecule modulators of TRP-P8 activity DENDREON CORP (US) 2016-07-20 EP disclosed
US-8618155-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-31 US disclosed
US-8614243-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-24 US disclosed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP disclosed
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-09-06 US disclosed
CN-101420942-A Small-molecule modulators of TRP-P8 activity DENDREON CORP (US) 2009-04-29 CN disclosed
EP-1986622-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-11-05 EP disclosed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US disclosed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US disclosed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity TRPC4, TRPC3, TRPC1 HRH1 907/4885MTOR 1539/4885RAB9A 2630/4885
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HRH1 907/4885MTOR 1539/4885RAB9A 2630/4885
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HRH1 907/4885MTOR 1539/4885RAB9A 2630/4885
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 HRH1 907/4885MTOR 1539/4885RAB9A 2630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.